DUBLIN--(BUSINESS WIRE)--The "Hematology Tests - Medical Devices Pipeline Assessment, 2019" report has been added to ResearchAndMarkets.com's offering.
This report provides an overview of Hematology Tests currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hematology Tests pipeline products.
Scope
- Extensive coverage of the Hematology Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Hematology Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Hematology Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Key Topics Covered
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Hematology Tests Overview
3 Products under Development
3.1 Hematology Tests - Pipeline Products by Stage of Development
3.2 Hematology Tests - Pipeline Products by Segment
3.3 Hematology Tests - Pipeline Products by Territory
3.4 Hematology Tests - Pipeline Products by Regulatory Path
3.5 Hematology Tests - Pipeline Products by Estimated Approval Date
4 Hematology Tests - Pipeline Products under Development by Companies
4.1 Hematology Tests Companies - Pipeline Products by Stage of Development
4.2 Hematology Tests - Pipeline Products by Stage of Development
5 Hematology Tests Companies and Product Overview
5.1 Aptitude Medical Systems Inc
5.2 BioMedomics Inc
5.3 Biosurfit, SA
5.4 Correlia Biosystems, Inc.
5.5 DxDiscovery, Inc.
5.6 Dynasil Corporation of America
5.7 ET Healthcare Inc
5.8 genedrive plc
5.9 Group K Diagnostics
5.10 hemCheck Sweden AB
5.11 Ohio State University
5.12 PortaScience Inc
5.13 Retham Technologies LLC
5.14 Sanguina LLC
5.15 Siemens Healthineers AG
5.16 T2 Biosystems Inc
5.17 University of Glasgow
5.18 University of Melbourne
6 Hematology Tests - Recent Developments
6.1 Oct 16, 2019: Orgenesis announces Co-Development Agreement with Accellix
6.2 Sep 30, 2019: Halo Labs provides Oregon business update company projects record September sales orders in Oregon
6.3 Sep 16, 2019: Sysmex America joins Clinical Lab 2.0 Movement to support collaboration around value-based healthcare
6.4 Sep 11, 2019: Bio-Rad files new lawsuit against 10X Genomics for Patent Infringement
6.5 Sep 10, 2019: EKF Diagnostics Holdings: Half-year Report
6.6 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership
6.7 Aug 26, 2019: Halo Labs awarded two permanent licenses at second California facility
6.8 Aug 14, 2019: Biohit Group half year financial report 2019
6.9 Aug 14, 2019: Accellix announces the appointment of Charles Piazza to its board of directors
6.10 Aug 12, 2019: Halo Labs reports Q2 2019 financial results
6.11 Aug 08, 2019: Quidel reports second quarter 2019 Financial Results
6.12 Aug 01, 2019: Bio-Rad reports second-quarter 2019 financial results
6.13 Jul 29, 2019: Siemens Healthineers continues to drive growth forward
6.14 Jul 29, 2019: Changes in the Managing Board of Siemens Healthineers
6.15 Jul 24, 2019: Delaware District Court grants Bio-Rad's Motion for Permanent Injunction against 10X Genomics
6.16 Jul 16, 2019: Universal Biosensors: Commentary on Q2 2019 Appendix 4C cash flow summary
6.17 Jul 15, 2019: Consort Medical: Incident at the Aesica Cramlington API facility
6.18 Jul 15, 2019: EKF Diagnostics Holdings: Trading update
6.19 Jul 01, 2019: Disgraced Theranos founder Elizabeth Holmes to stand trial in 2020
6.20 Jun 26, 2019: Universal Biosensors: Business Update
6.21 Jun 18, 2019: Halo Labs intends to appoint Ms. Louisa Mojela as Chairman of the Board upon closing of bophelo bioscience acquisition
6.22 Jun 13, 2019: Consort Medical reports a solid performance and announces new contract awards
6.23 Jun 01, 2019: Greg Milosevich appointed President of Beckman Coulter Life Sciences
6.24 May 20, 2019: Akers Biosciences reports Q1 2019 earnings
6.25 May 08, 2019: Bio-Rad reports first quarter 2019 financial results
6.26 May 08, 2019: Quidel reports first quarter 2019 financial results
6.27 May 02, 2019: Siemens Healthineers posts strong revenue and profit growth in the second quarter
6.28 May 01, 2019: Halo Labs moves west
6.29 Apr 23, 2019: Universal Biosensors: Commentary on Q1 2019 Appendix 4C cash flow summary
6.30 Apr 22, 2019: Bio-Rad Laboratories names Andrew Last as executive vice president and chief operating officer
6.31 Apr 02, 2019: Bio-Rad Laboratories appoints Ilan Daskal as executive vice president and chief financial officer
6.32 Apr 01, 2019: Akers Biosciences reports fiscal year 2018 earnings
6.33 Mar 13, 2019: EKF Diagnostics Holdings: Final results
6.34 Mar 08, 2019: Universal Biosensors announces resignation of CEO Rick Legleiter
6.35 Feb 28, 2019: Bio-Rad Laboratories announces fourth-quarter and full-year 2018 financial results
6.36 Feb 20, 2019: Biohit group financial statement release 2018
6.37 Feb 13, 2019: Quidel Reports Fourth Quarter and Full Year 2018 Financial Results
6.38 Feb 11, 2019: Siemens Healthineers to invest EUR 350 million in new Campus Forchheim
6.39 Feb 05, 2019: Akers Biosciences: Further Re. Directorate change
6.40 Jan 29, 2019: Universal Biosensors: Commentary on FY 2018
6.41 Jan 25, 2019: Introducing DiaSys' new CEO Dr. Jan Gorka
6.42 Jan 07, 2019: Quidel Announces Preliminary Revenue for Fourth Quarter 2018
6.43 Jan 03, 2019: Bio-Rad finance chief to retire
6.44 Jan 03, 2019: Christine Tsingos announces plans to retire as CFO of Bio-Rad Laboratories
For more information about this report visit https://www.researchandmarkets.com/r/dtgpka
